Trial Profile
Phase I trial of multiple ascending doses of NKTR 181 in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Feb 2012
Price :
$35
*
At a glance
- Drugs Oxycodegol (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 27 Feb 2012 Results published in a Nektar Therapeutics media release.
- 14 Dec 2011 Full results have been accepted for presentation at the 2012 American Academy of Pain Medicine's 28th Annual Meeting, according to a Nektar Therapeutics media release.
- 14 Dec 2011 Status changed from recruiting to completed, according to a Nektar Therapeutics media release.